These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2663231)

  • 1. Malignant hypertension, fibrinoid deposition, and fibrinogen electrophoresis.
    Dardik BN; Shainoff JR; Chatelain RE; DiBello PM; Ferrario CM
    Cleve Clin J Med; 1989 Jun; 56(4):451-6. PubMed ID: 2663231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Derivatives of fibrinogen and fibrin during defibrase therapy. Separation of high and low molecular weight derivatives of fibrinogen and fibrin by agarose gel filtration.
    Asbeck F; Lechler E; Martin M; van de Loo J
    Haemostasis; 1974; 3(5-6):340-7. PubMed ID: 4468232
    [No Abstract]   [Full Text] [Related]  

  • 3. GPR-phoresis, a novel approach to determining fibrin monomer and other macromolecular derivatives of fibrinogen and fibrin in blood.
    Shainoff JR; Urbanic DA; DiBello PM; Valenzuela V
    Blood Coagul Fibrinolysis; 1993 Feb; 4(1):87-92. PubMed ID: 8457658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic degradation products from fibrinogen and fibrin with special respect to non-covalently associated complexes. Influence of fibrin crosslinking. Lysability and other properties.
    Feddersen C
    Scand J Clin Lab Invest Suppl; 1983; 166():1-60. PubMed ID: 6226084
    [No Abstract]   [Full Text] [Related]  

  • 5. [Selected indices of blood clotting and fibrinolysis in patients with malignant hypertension].
    Berent H; Uchman B; Skórka B; Rymaszewski Z
    Pol Tyg Lek; 1977 May; 32(18):665-7. PubMed ID: 866246
    [No Abstract]   [Full Text] [Related]  

  • 6. [The fibrinogen-fibrin-fibrinolysis system in rheumatoid arthritis].
    Belitskaia GA; Palienko IA; Shevchenko LI; Fedorova NE
    Vrach Delo; 1989 Jan; (1):47-50. PubMed ID: 2718445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunoelectrophoretic study of fibrinogen and of degradation products of fibrinogen and fibrin].
    Karpinskaia VM
    Probl Gematol Pereliv Krovi; 1968 Jan; 13(1):53-6. PubMed ID: 5736826
    [No Abstract]   [Full Text] [Related]  

  • 8. [A comprehensive laboratory evaluation of changes in the fibrinogen molecule in the diagnosis of acquired coagulopathy conditions].
    Siatkovskiĭ VA; Azarova LA; Vasilenko PL
    Lab Delo; 1989; (8):45-8. PubMed ID: 2477628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrin derivatives, plasma hemoglobin and glomerular fibrin deposition in experimental intravascular coagulation.
    Beller FK; Theiss W
    Thromb Diath Haemorrh; 1973 May; 29(2):363-74. PubMed ID: 4586906
    [No Abstract]   [Full Text] [Related]  

  • 10. The structure of soluble fibrin complexes and fibrin degradation products after Echis carinatus bite.
    Edgar W; Warrell MJ; Warrell DA; Prentice CR
    Br J Haematol; 1980 Mar; 44(3):471-81. PubMed ID: 7378311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant arterial hypertension. A review of 88 patients.
    Kuzmanić D; Marinković M; Winter-Fudurić I; Ficović P; Roncević T
    Przegl Lek; 1985; 42(3):335-8. PubMed ID: 4048512
    [No Abstract]   [Full Text] [Related]  

  • 12. [Fibrinogen degradation products, soluble fibrin and antithrombin III in toxic goiter patients].
    Panchenko VM; Salakhidinov Z; Khaĭkina MB
    Probl Endokrinol (Mosk); 1979; 25(1):11-5. PubMed ID: 581702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative immunochemical determination of degradation products of fibrinogen and-or fibrin with high voltage electrophoresis.
    Niléhn JE
    Scand J Haematol Suppl; 1971; 13():215-7. PubMed ID: 5290683
    [No Abstract]   [Full Text] [Related]  

  • 14. Significance of fibrin-degradation products (F.D.P.) determinations in human glomerulopathies.
    Dewan R; Ahooja P; Rizvi SN; Gulati PD
    J Assoc Physicians India; 1978 Jul; 26(7):605-12. PubMed ID: 721767
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute arterial fibrinoid deposition and ischaemic parenchymal damage of the kidney. Pathogenic factors in the development of malignant hypertension.
    Chatelain RE; Dardik BN; Shainoff JR
    J Pathol; 1983 Oct; 141(2):125-42. PubMed ID: 6363644
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical implications of analyses of fibrinogen and fibrin-derivatives in DIC].
    Magari Y; Ito M; Itoga T
    Rinsho Ketsueki; 1986 Oct; 27(10):1992-2007. PubMed ID: 3820619
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study on high molecular weight fibrinogen/fibrin complex (HMWFC) (author's transl)].
    Suzuki S; Matsui N
    Rinsho Ketsueki; 1979 Aug; 20(8):901-9. PubMed ID: 502006
    [No Abstract]   [Full Text] [Related]  

  • 18. [Interaction of fibrinogen and fibrin with protamine sulfate].
    Mikhalovskaia LI; Varetskaia TV; Belitser VA
    Ukr Biokhim Zh (1978); 1988; 60(4):3-9. PubMed ID: 3188253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrin and fibrinogen-related antigens in systemic sclerosis (scleroderma).
    Falanga V; Kruskal JB; Franks JJ
    J Am Acad Dermatol; 1991 Nov; 25(5 Pt 1):771-5. PubMed ID: 1802898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of fibrin-fibrinogenolysis on the determination of the fibrinogen content and fibrin-fibrinogen degradation products (FDP) by means of the fibrin polymerization time (FPT test)].
    Vorlová Z; Dyr IE
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):967-70. PubMed ID: 94893
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.